Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study

Driessen Johanna H. M.; van den Bergh Joop P. W.; van Onzenoort Hein A. W.; Henry Ronald M. A.; Leufkens Hubert G. M.; de Vries Frank

首页> 外文期刊>Diabetes, obesity & metabolism >Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study

【24h】

Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study

机译：长期使用二肽基肽酶-4抑制剂和骨折风险：一种近六程群体的群组研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To investigate the association between long-term dipeptidyl peptidase-4 (DPP-4) inhibitor use and risk of fracture among people with type 2 diabetes mellitus (T2DM).

机译：目的：探讨长期二肽肽肽酶-4（DPP-4）抑制剂使用的关联和2型糖尿病（T2DM）的人群中的骨折的风险。

著录项

来源
《Diabetes, obesity & metabolism》 |2017年第3期|共8页
作者
Driessen Johanna H. M.; van den Bergh Joop P. W.; van Onzenoort Hein A. W.; Henry Ronald M. A.; Leufkens Hubert G. M.; de Vries Frank;
展开▼
作者单位

Utrecht Inst Pharmaceut Sci Div Pharmacoepidemiol &

Clin Pharmacol Utrecht Netherlands;

Viecuri Med Ctr Dept Internal Med Venlo Netherlands;

Maastricht Univ Med Ctr Dept Clin Pharm &

Toxicol Maastricht Netherlands;

Maastricht Univ Med Ctr Dept Med Maastricht Netherlands;

Utrecht Inst Pharmaceut Sci Div Pharmacoepidemiol &

Clin Pharmacol Utrecht Netherlands;

Utrecht Inst Pharmaceut Sci Div Pharmacoepidemiol &

Clin Pharmacol Utrecht Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
cohort-study; CPRD; DPP-4 inhibitor; fracture; type 2 diabetes mellitus;

机译：队列研究;CPRD;DPP-4抑制剂;骨折;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study [J] . Driessen Johanna H. M., van den Bergh Joop P. W., van Onzenoort Hein A. W., Diabetes, obesity & metabolism . 2017,第3期

机译：长期使用二肽基肽酶-4抑制剂和骨折风险：一种近六程群体的群组研究
2. Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study [J] . Jong-Mi Seong, Jong Joo Kim, Hae Jin Kim, Cardiovascular Diabetology . 2020,第1期

机译：用Dapagliflozin和二肽肽肽酶-4抑制剂治疗2型糖尿病患者心力衰竭风险和医疗费用的比较：全国群体的群组研究
3. Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case-control studies [J] . Wang Chen-Yu, Fu Shau-Huai, Yang Rong-Sen, Pharmacoepidemiology and drug safety . 2019,第4期

机译：使用二肽基肽酶-4抑制剂和关节痛的风险：基于人群的群体和嵌套病例对照研究
4. Model QSAR Classification Using Conv1D-LSTM of Dipeptidyl Peptidase-4 Inhibitors [C] . Adawiyah Ulfa, Alhadi Bustamam, Arry Yanuar, International Conference on Artificial Intelligence and Mechatronics Systems . 2021

机译：使用DIP肽基肽酶-4抑制剂的CANC1D-LSTM模型QSAR分类
5. Proton pump inhibitors and the risk of fractures in older adults: A population-based retrospective cohort study. [D] . Harding, Barbara. 2016

机译：质子泵抑制剂和老年人骨折的风险：一项基于人群的回顾性队列研究。
6. Intensification with dipeptidyl peptidase-4 inhibitor insulin or thiazolidinediones and risks of all-cause mortality cardiovascular diseases and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study [O] . Carlos K. H. Wong, Kenneth K. C. Man, Margaret Shi, 2019

机译：二甲双胍-磺脲类双重疗法患者中二肽基肽酶-4抑制剂胰岛素或噻唑烷二酮类药物的强化治疗以及全因死亡率心血管疾病和严重低血糖的风险：一项回顾性队列研究
7. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study [O] . Carlos K. H. Wong, Kenneth K. C. Man, Margaret Shi, 2019

机译：用二肽肽酶-4抑制剂，胰岛素或噻唑烷基因的增强和全甲醛 - 磺酰脲类二元治疗患者的死亡率，心血管疾病和严重低血基血症的风险：回顾性队列研究

Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study

摘要

著录项

相似文献

相关主题

期刊订阅